Wells Fargo Starts Calithera Biosciences (CALA) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/15/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- Lucid Group shares quickly cut in half on report of potential bankruptcy
- HSBC Downgrades IBM (IBM) to Reduce, 'Stretched Valuation'
Citi Starts Calithera Biosciences (CALA) at Buy
October 27, 2014 8:45 AM EDTCiti initiated coverage on Calithera Biosciences (NASDAQ: CALA) with a Buy rating and a price target of $15.00.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... MoreLeerink Swann Starts Calithera Biosciences (CALA) at Outperform
October 27, 2014 7:10 AM EDTLeerink Swann initiated coverage on Calithera Biosciences (NASDAQ: CALA) with an Outperform rating and a price target of $13.00.
For an analyst ratings summary and ratings history on Calithera Biosciences click here. For more ratings news on Calithera Biosciences click here.
Shares of Calithera Biosciences closed at $11.04 yesterday.
... More